🔎 Trials Near Me

Почетна › Рак јајника › Kalifornija › Irvine

Kliničke studije za Рак јајника u gradu Irvine, CA

14 studija za Рак јајника traži učesnike na lokacijama u gradu Irvine i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Тражи се учесникФаза 2/3
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07001748

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Тражи се учесникФаза 3
  • City of Hope Lennar Foundation Cancer Center ( Site 0024), Irvine
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT06824467

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Тражи се учесникФаза 3
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Kaiser Permanente-Irvine, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Тражи се учесник
  • City of Hope at Irvine Lennar, Irvine
  • Kaiser Permanente-Irvine, Irvine
Узраст од 35 до 50 · Жене · Ажурирано 6. 11. 2026. · NCT04251052

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Тражи се учесникФаза 3
  • City of Hope Lennar, Irvine
  • Kaiser Permanente Zion Medical Center, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Тражи се учесникФаза 1/2
  • City of Hope, Irvine, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Тражи се учесникФаза 2
  • Kaiser Permanente - Irvine /ID# 276924, Irvine
Узраст 18 и старији · Жене · Ажурирано 20. 10. 2026. · NCT06890338

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

Тражи се учесник
  • City of Hope at Irvine Lennar, Irvine
Узраст 18 и старији · Жене · Ажурирано 16. 10. 2026. · NCT07741968

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

Тражи се учесникФаза 1
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07278336

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Тражи се учесникФаза 1/2
  • Research Site, Irvine
Узраст од 18 до 130 · Оба пола · Ажурирано 5. 10. 2026. · NCT05797168

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Тражи се учесникФаза 1/2
  • The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Узраст 18 и старији · Жене · Ажурирано 24. 9. 2026. · NCT04590326

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Тражи се учесникФаза 2
  • City of Hope Lennar, Irvine
Узраст од 18 до 100 · Жене · Ажурирано 13. 7. 2026. · NCT05887609

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

Тражи се учесникФаза 1/2
  • City of Hope, Irvine
Узраст од 18 до 75 · Жене · Ажурирано 13. 7. 2026. · NCT07322094

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Irvine
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Рак јајника u drugim gradovima

Ostale studije u gradu Irvine

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.